The structural and biochemical characterization of broadly neutralizing anti-HIV-1 antibodies (bNAbs) has been essential in guiding the design of potential vaccines to prevent infection by HIV-1. While these studies have revealed critical mechanisms by which bNAbs recognize and/or accommodate N-glycans on the trimeric envelope glycoprotein (Env), they have been limited to the visualization of high-mannose glycan forms only, since heterogeneity introduced from the presence of complex glycans makes it difficult to obtain high-resolution structures. 3.5 and 3.9 Å resolution crystal structures of the HIV-1 Env trimer with fully processed and native glycosylation were solved, revealing a glycan shield of high-mannose and complex-type N-glycans t...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The HIV-1 envelope (Env) glycoprotein is the primary target of the humoral immune response and a cr...
The structural and biochemical characterization of broadly neutralizing anti-HIV-1 antibodies (bNAbs...
The structural and biochemical characterization of broadly neutralizing anti-HIV-1 antibodies (bNAbs...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
SummarySecretory and membrane proteins from mammalian cells undergo post-translational modifications...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
The HIV-1 envelope glycoprotein trimer (Env) is covered by an extensive array of glycans that shield...
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutr...
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutr...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
SummaryThe HIV-1 envelope glycoprotein trimer is covered by an array of N-linked glycans that shield...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The HIV-1 envelope (Env) glycoprotein is the primary target of the humoral immune response and a cr...
The structural and biochemical characterization of broadly neutralizing anti-HIV-1 antibodies (bNAbs...
The structural and biochemical characterization of broadly neutralizing anti-HIV-1 antibodies (bNAbs...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
SummarySecretory and membrane proteins from mammalian cells undergo post-translational modifications...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
The HIV-1 envelope glycoprotein trimer (Env) is covered by an extensive array of glycans that shield...
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutr...
HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutr...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
SummaryThe HIV-1 envelope glycoprotein trimer is covered by an array of N-linked glycans that shield...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
SummaryA highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The hi...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The HIV-1 envelope (Env) glycoprotein is the primary target of the humoral immune response and a cr...